November 7, 2026 · Industry news
How consortia like the Coalition for Health AI (CHAI) and VALID AI establish independent, standardized testing labs to evaluate commercial clinical AI claims.

Commercial health insurers have faced fierce legal and regulatory scrutiny for deploying automated algorithms that deny medical claims and prior authorizations in seconds without human clinical review. A wave of new state statutes and federal guidelines mandates that licensed medical professionals personally review any automated denial.
In 2023 and 2024, investigative reporting and federal congressional inquiries exposed a deeply troubling practice across several major commercial health insurers: the deployment of automated algorithmic systems that review and deny medical claims in batch. Systems were documented reviewing hundreds of claims simultaneously, generating clinical denials in an average of 1.2 seconds per patient file without a human physician ever opening the patient's medical chart.
Physicians and patient advocates expressed outrage, pointing out that patients with debilitating spinal stenosis, pediatric speech delays, and cancer therapies were denied medically necessary care by uncalibrated algorithms optimized solely to control insurer loss ratios.
In response to public outcry, state legislatures moved aggressively to regulate payer algorithms. Leading the nation, California enacted landmark statute Senate Bill 1120 (SB 1120), signed into law to regulate algorithmic utilization review.
Under SB 1120 and companion statutes enacted across New York, Pennsylvania, and Maryland, health insurers are strictly prohibited from utilizing artificial intelligence or automated decision-making software to deny, reduce, or modify healthcare services. While insurers may use algorithms to streamline administrative routing or approve claims, any decision to deny coverage based on medical necessity must be personally reviewed and executed by a licensed, qualified physician practicing in the relevant clinical specialty.
At the federal level, the Centers for Medicare & Medicaid Services (CMS) reinforced these protections through regulatory guidance governing Medicare Advantage (MA) plans. Under finalized CMS rules, MA plans are prohibited from using proprietary internal algorithms to deny coverage that traditional Medicare would cover.
Furthermore, CMS mandates that insurers disclose the exact clinical criteria used in utilization management software, prohibiting proprietary 'black box' coverage rules and requiring plans to grant physicians direct access to peer-to-peer discussions with human medical directors.
These statutory developments provide significant leverage for medical practice revenue cycle teams fighting improper payer denials:
Fluent stands firmly on the side of healthcare providers and patients. Fluent Assistant and its administrative tools help clinic staff organize complete clinical documentation packets, ensuring that authorization requests contain the robust, source-verified clinical evidence necessary to withstand payer scrutiny.
By structuring patient clinical context and tracking authorization milestones in staff worklists, Fluent helps practices maintain compliant, efficient workflows that hold commercial payers accountable to the law.
Published November 7, 2026. Sources are linked above; operational recommendations are Fluent’s editorial analysis.
Discover how healthcare teams are transforming patient access with Fluent.